1Dept of Pathology, Harvard Medical School and Howard Hughes Medical Institute, Boston, MA 02115, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Deregulated cyclin-dependent kinase 5 (CDK5) activity is implicated in mutant SOD1-mediated diseases. Inhibiting CDK5 may promote motor neuron survival, suggesting a therapeutic target for neurodegenerative conditions like ALS.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: